Coles N Anthony
SEC-identified person · CIK 1197018 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Regeneron Pharmaceuticals, INC. REGN | Director | filed 2017–2026 |
| Cerevel Therapeutics Holdings, Inc. CERF | Director · See Remarks | filed 2020–2024 |
| Yumanity Therapeutics, INC. YMTX | Director · Executive Chair | filed 2020–2021 |
| Mckesson Corp MCK | Director | filed 2014–2020 |
| Crispr Therapeutics AG CRSP | Director | filed 2016–2017 |
| Onyx Pharmaceuticals INC ONXX | Director · President & CEO | filed 2008–2013 |
| Campus Crest Communities, Inc. CCG | Director | filed 2010–2013 |
| Laboratory Corp of America Holdings LH | Director | filed 2011–2013 |
| NPS Pharmaceuticals INC NSPS | Director · President, COO & Director | filed 2006–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.